306 related articles for article (PubMed ID: 35166235)
1. Colorectal cancer: the facts in the case of the microbiota.
Clay SL; Fonseca-Pereira D; Garrett WS
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.
Ahmad A; Mahmood N; Raza MA; Mushtaq Z; Saeed F; Afzaal M; Hussain M; Amjad HW; Al-Awadi HM
Heliyon; 2024 Apr; 10(8):e29495. PubMed ID: 38655310
[TBL] [Abstract][Full Text] [Related]
4. Biofilms and core pathogens shape the tumor microenvironment and immune phenotype in colorectal cancer.
Kvich L; Fritz BG; Zschach H; Terkelsen T; Raskov H; Høst-Rasmussen K; Jakobsen MR; Gheorghe AG; Gögenur I; Bjarnsholt T
Gut Microbes; 2024; 16(1):2350156. PubMed ID: 38726597
[TBL] [Abstract][Full Text] [Related]
5. Intestinal bacteria and colorectal cancer: etiology and treatment.
Dougherty MW; Jobin C
Gut Microbes; 2023; 15(1):2185028. PubMed ID: 36927206
[TBL] [Abstract][Full Text] [Related]
6. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
[TBL] [Abstract][Full Text] [Related]
7. Microbial markers in colorectal cancer detection and/or prognosis.
Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence.
Vacante M; Ciuni R; Basile F; Biondi A
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33182693
[TBL] [Abstract][Full Text] [Related]
9. Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer.
Qin Y; Tong X; Mei WJ; Cheng Y; Zou Y; Han K; Yu J; Jie Z; Zhang T; Zhu S; Jin X; Wang J; Yang H; Xu X; Zhong H; Xiao L; Ding PR
Nat Commun; 2024 Apr; 15(1):3396. PubMed ID: 38649355
[TBL] [Abstract][Full Text] [Related]
10. Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer.
Ayabe RI; White MG
Front Biosci (Landmark Ed); 2024 Apr; 29(4):152. PubMed ID: 38682201
[TBL] [Abstract][Full Text] [Related]
11. Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy.
Zhang J; Wang P; Wang J; Wei X; Wang M
Pharmacol Res; 2024 May; 203():107185. PubMed ID: 38615875
[TBL] [Abstract][Full Text] [Related]
12. The microbial landscape of colorectal cancer.
White MT; Sears CL
Nat Rev Microbiol; 2024 Apr; 22(4):240-254. PubMed ID: 37794172
[TBL] [Abstract][Full Text] [Related]
13. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
[TBL] [Abstract][Full Text] [Related]
14. From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential.
Mignini I; Piccirilli G; Galasso L; Termite F; Esposto G; Ainora ME; Gasbarrini A; Zocco MA
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256554
[TBL] [Abstract][Full Text] [Related]
15. Exploiting lactic acid bacteria for colorectal cancer: a recent update.
Chen Y; Yang B; Zhao J; Ross RP; Stanton C; Zhang H; Chen W
Crit Rev Food Sci Nutr; 2024; 64(16):5433-5449. PubMed ID: 36530047
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation.
Garvey M
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672096
[TBL] [Abstract][Full Text] [Related]
17. Bacterial antigens unleash tumor-targeting immunity.
Boeck N; Trajanoski Z; Galluzzi L
Cell Host Microbe; 2023 Dec; 31(12):1945-1947. PubMed ID: 38096784
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and implications of pKs-positive Escherichia coli in colorectal cancer.
de Souza JB; de Almeida Campos LA; Palácio SB; Brelaz-de-Castro MCA; Cavalcanti IMF
Life Sci; 2024 Mar; 341():122462. PubMed ID: 38281542
[TBL] [Abstract][Full Text] [Related]
19. Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation.
Li B; Zu M; Jiang A; Cao Y; Wu J; Shahbazi MA; Shi X; Reis RL; Kundu SC; Xiao B
Biomaterials; 2024 Jun; 307():122530. PubMed ID: 38493672
[TBL] [Abstract][Full Text] [Related]
20. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Wang M; Rousseau B; Qiu K; Huang G; Zhang Y; Su H; Le Bihan-Benjamin C; Khati I; Artz O; Foote MB; Cheng YY; Lee KH; Miao MZ; Sun Y; Bousquet PJ; Hilmi M; Dumas E; Hamy AS; Reyal F; Lin L; Armistead PM; Song W; Vargason A; Arthur JC; Liu Y; Guo J; Zhou X; Nguyen J; He Y; Ting JP; Anselmo AC; Huang L
Nat Biotechnol; 2023 Sep; ():. PubMed ID: 37749267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
